About Psynova Neurotech
Psynova Neurotech was established in 2005 by Prof. Sabine Bahn MD, Ph.D, MRCPsych, and Prof Chris Lowe PhD of the University of Cambridge (UK), for the commercial development and exploitation of novel biomarkers for neuropsychiatric illnesses.
For co-founder Sabine Bahn, a psychiatrist by training, establishing Psynova Neurotech and the Centre for Neuropsychiatric Research in Cambridge, is a personal endeavour, having grown up in Germany with a father suffering from Bipolar disorder.
Determined to raise the standard of research in this area, and bring mental disorders out of the shadows, Bahn talks of addressing the stigmatisation and dreams of developing a biochemical test that could put an end to the waiting and arrest the disease in the early stages.
Please use the menu on the left to find out more about Psynova Neurotech’s history, funding and team.